14 results
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
18 Dec 23
Third party tender offer statement (amended)
6:59am
, transaction costs, risks that the proposed acquisition disrupts current plans and operations or adversely affects employee retention, potentially diverting
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
4 Dec 23
Third party tender offer statement (amended)
7:04am
costs, risks that the proposed acquisition disrupts current plans and operations or adversely affects employee retention, potentially diverting
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
17 Nov 23
Third party tender offer statement (amended)
6:53am
costs, risks that the proposed acquisition disrupts current plans and operations or adversely affects employee retention, potentially diverting
SC TO-T/A
EX-99
LLY
Lilly(Eli) & Co
15 Nov 23
Third party tender offer statement (amended)
6:51am
, transaction costs, risks that the proposed acquisition disrupts current plans and operations or adversely affects employee retention, potentially
SC TO-T/A
EX-99
sswxmnjleiuf7 mzv
8 Nov 23
Third party tender offer statement (amended)
5:06pm
SC TO-C
3e7 0vdkyw7ze1rp9u
3 Oct 23
Information about tender offer
4:30pm
SC TO-C
EX-99.1
8dj8xqh3vzv8
3 Oct 23
Information about tender offer
4:30pm
SC14D9C
EX-99.4
uadxrlojetvsqka929vi
3 Oct 23
Written communication relating to third party tender offer
7:37am
SC14D9C
EX-2.1
r2xo p8710fn
3 Oct 23
Written communication relating to third party tender offer
7:37am
8-K
EX-99.4
4x5x4 6zth
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-2.1
n71 f3rvn9d
3 Oct 23
Tender and Support Agreement
7:35am
DEF 14A
ogm 2pvqc
28 Apr 22
Definitive proxy
8:36am
- Prev
- 1
- Next